Cargando…
miR-155 Overexpression in OT-1 CD8(+) T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen
Therapy by adoptive transfer of ex vivo-expanded tumor-infiltrating or genetically modified T cells may lead to impressive clinical responses. However, there is a need to improve in vivo persistence and functionality of the transferred T cells, in particular, to face the highly immunosuppressive env...
Autores principales: | Monnot, Gwennaëlle C., Martinez-Usatorre, Amaia, Lanitis, Evripidis, Lopes, Silvia Ferreira, Cheng, Wan-Chen, Ho, Ping-Chih, Irving, Melita, Coukos, George, Donda, Alena, Romero, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994712/ https://www.ncbi.nlm.nih.gov/pubmed/32021906 http://dx.doi.org/10.1016/j.omto.2019.12.008 |
Ejemplares similares
-
Targeting the tumor vasculature to enhance T cell activity
por: Lanitis, Evripidis, et al.
Publicado: (2015) -
Correction to: CART cells are prone to Fas- and DR5-mediated cell death
por: Tschumi, Benjamin O., et al.
Publicado: (2018) -
Prophylactic vs. Therapeutic Treatment With P2Et Polyphenol-Rich Extract Has Opposite Effects on Tumor Growth
por: Lasso, Paola, et al.
Publicado: (2018) -
Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T Cells
por: Irving, Melita, et al.
Publicado: (2021) -
Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression
por: Lanitis, Evripidis, et al.
Publicado: (2020)